AGWCA
CLB icon

Annis Gardner Whiting Capital Advisors’s Core Laboratories CLB Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36
Closed -$605 – 502
2026
Q1 		$605 Hold
36
– – ﹤0.01% 1202
2025
Q4 		$578 Buy
+36
New +$536 ﹤0.01% 1099

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Annis Gardner Whiting Capital Advisors's CLB Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 36 shares — an estimated $605 sold.

Annis Gardner Whiting Capital Advisors first reported a position in CLB in Q4 2025 and held it in 2 quarters. The position peaked at $605 in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 36 Core Laboratories shares in Q2 2026, an estimated $605.
  • Annis Gardner Whiting Capital Advisors first reported a position in Core Laboratories in Q4 2025 and held it in 2 quarters.
  • Annis Gardner Whiting Capital Advisors's Core Laboratories position peaked at $605 in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.